flutamide has been researched along with butylhydroxybutylnitrosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaza, H; Imada, S; Koiso, K; Otani, M | 1 |
| Akaza, H; Ami, Y; Ideyama, Y; Imada, S; Koiso, K; Takenaka, T | 1 |
2 other study(ies) available for flutamide and butylhydroxybutylnitrosamine
| Article | Year |
|---|---|
[Effects of androgen regulation system on bladder carcinogenesis in male mice].
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Animals; Butylhydroxybutylnitrosamine; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Leuprolide; Male; Mice; Mice, Inbred C3H; Orchiectomy; Urinary Bladder Neoplasms | 1995 |
Promoting effects and mechanisms of action of androgen in bladder carcinogenesis in male rats.
Topics: Administration, Oral; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Enzyme Inhibitors; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Immunohistochemistry; Leuprolide; Male; Mice; Mice, Inbred C3H; Oxidoreductases; Rats; Rats, Wistar; Urinary Bladder Neoplasms | 1997 |